$13.56
+0.01 (+0.07%)
As of Aug 8, 1:34 AM ET ·
Analyst Consensus
Strong Sell
13
Analysts
Moderate
Coverage
Buy 0 0%
Hold 7 54%
Sell 6 46%
Price Target
Analyst Price Target +566.7% upside
Low Target $73.92
Average Target $90.40
High Target $125.40
Current Price $13.56
Current
$13.56
Target
$90.40
$73.92 $90.40 avg $125.40
Scenario Analysis
Bear Case
$73.92
445.1%
Low target
Base Case
$90.40
+566.7%
Avg target
Bull Case
$125.40
+824.8%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$13.60
-0.3% from high
52-Week Low
$5.69
+138.3% from low
50-Day SMA
$7.87
+72.3% vs SMA
200-Day SMA
$8.85
+53.2% vs SMA
RSI (14)
32.1
Neutral
Target vs 52W High
$90.40
+564.7% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
EPS Est: $0.93
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Sell 44 52% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%